Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ESPR - Should You Buy These 4 Biotech Stocks With Recent Drug Approvals?


ESPR - Should You Buy These 4 Biotech Stocks With Recent Drug Approvals?

The Food and Drug Administration (FDA) made numerous drug approval decisions in the first quarter. These binary events can cause stock prices to skyrocket or plummet depending on the outcome.

Here we explore four companies that successfully attained FDA approval. It marked the first drug ever approved for three of these companies. With the FDA decision in the rearview mirror, should investors look to own these stocks? 

Image Source: Getty Images.

Continue reading

Stock Information

Company Name: Esperion Therapeutics Inc.
Stock Symbol: ESPR
Market: NASDAQ
Website: esperion.com

Menu

ESPR ESPR Quote ESPR Short ESPR News ESPR Articles ESPR Message Board
Get ESPR Alerts

News, Short Squeeze, Breakout and More Instantly...